Certara's Participation in Notable Investor Conferences
Certara, Inc. (Nasdaq: CERT), a leader in model-informed drug development, has exciting plans to engage with the investment community. The company has announced its participation in upcoming investor conferences that promise to offer intriguing insights into its operations and future prospects.
Details of the Baird Global Healthcare Conference
One of the key events on Certara's calendar is the Baird Global Healthcare Conference. It is scheduled for Tuesday, September 9, at 10:15 a.m. ET. This conference is a significant venue for healthcare investment discussions and showcases leading companies in the sector. Investors can look forward to updates on Certara's latest innovations and strategic direction during this session.
Highlights from the Morgan Stanley Annual Global Healthcare Conference
Following the Baird event, Certara will also be present at the Morgan Stanley 23rd Annual Global Healthcare Conference. This event is set for Wednesday, September 10, at 12:20 p.m. ET, and promises to be another critical opportunity for investors to gather insights. Here, Certara's management team will share valuable information about the company's performance, projects, and future aspirations.
How to Access Live Webcasts
For those unable to attend the conferences in person, Certara offers live webcasts through its investor relations website. This feature allows participants to engage virtually and stay informed about the company's developments. Notably, the webcasts will be available for replay for at least 90 days following the events, ensuring that everyone has the chance to catch up on the discussions.
About Certara and Its Impact on Drug Development
Certara is revolutionizing the healthcare landscape through its innovative biosimulation software and services, which enhance traditional drug development processes. With over 2,400 clients, including biopharmaceutical companies, academia, and regulatory bodies, Certara plays a vital role in advancing the drug discovery field worldwide. By utilizing cutting-edge technology, the company significantly accelerates the development of medicines, benefiting patients and healthcare providers alike.
Connecting with Certara's Investor Relations
Investors and interested parties can reach out to Certara's Investor Relations for further inquiries. The contact person, David Deuchler from Gilmartin Group, is available for questions and discussions regarding the company's performance and future goals.
Frequently Asked Questions
What conferences will Certara be attending?
Certara will participate in the Baird Global Healthcare Conference and the Morgan Stanley Annual Global Healthcare Conference.
When is the Baird Global Healthcare Conference scheduled?
The Baird Global Healthcare Conference is set for Tuesday, September 9, at 10:15 a.m. ET.
How can I access the live webcasts of the conferences?
Live webcasts can be accessed through Certara's investor relations website, and they will be available for replay for at least 90 days afterward.
What is the main focus of Certara's services?
Certara focuses on accelerating drug development using biosimulation software and technology to transform traditional methods in drug discovery.
Who can I contact for investor relations inquiries?
David Deuchler from Gilmartin Group is the contact person for investor relations inquiries related to Certara.
